Orthopediatrics Corp Net Income Over Time
| KIDS Stock | USD 16.90 0.07 0.41% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Orthopediatrics Corp Performance and Orthopediatrics Corp Correlation. Orthopediatrics | Build AI portfolio with Orthopediatrics Stock |
Is there potential for Health Care Equipment & Supplies market expansion? Will Orthopediatrics introduce new products? Factors like these will boost the valuation of Orthopediatrics Corp. Expected growth trajectory for Orthopediatrics significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.96) | Revenue Per Share | Quarterly Revenue Growth 0.122 | Return On Assets | Return On Equity |
Understanding Orthopediatrics Corp requires distinguishing between market price and book value, where the latter reflects Orthopediatrics's accounting equity. The concept of intrinsic value - what Orthopediatrics Corp's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Orthopediatrics Corp's price substantially above or below its fundamental value.
Understanding that Orthopediatrics Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Orthopediatrics Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Orthopediatrics Corp's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Orthopediatrics Corp and related stocks such as Treace Medical Concepts, CeriBell, and SurModics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMCI | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (3.7 M) | (20.6 M) | (42.8 M) | (49.5 M) | (55.7 M) | (50.2 M) | (47.7 M) |
| CBLL | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (29.5 M) | (40.5 M) | (36.4 M) | (38.2 M) |
| RXST | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 27.6 M | (48.7 M) | (66.8 M) | (48.6 M) | (27.5 M) | (24.7 M) | (23.5 M) |
| TOI | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | (4 M) | (14.3 M) | (10.9 M) | 152 K | (83.1 M) | (64.7 M) | (58.2 M) | (55.3 M) |
| LAB | (23.6 M) | (22.5 M) | (19 M) | (15.8 M) | (52.8 M) | (53.3 M) | (76 M) | (60.5 M) | (59 M) | (64.8 M) | (53 M) | (59.2 M) | (190.1 M) | (74.7 M) | (138.9 M) | (125 M) | (118.7 M) |
| BVS | (22.4 M) | (22.4 M) | (22.4 M) | (22.4 M) | (12.9 M) | (34.1 M) | (18 M) | (1.6 M) | (12.2 M) | 6.9 M | 16.4 M | 19.4 M | (158.7 M) | (156.2 M) | (33.5 M) | (30.2 M) | (31.7 M) |
| EHAB | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 75 M | 111.1 M | (40.4 M) | (80.5 M) | (156.2 M) | (140.6 M) | (133.6 M) |
| EOLS | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (20.1 M) | (4.5 M) | (46.9 M) | (90 M) | (163 M) | (46.8 M) | (74.4 M) | (61.7 M) | (50.4 M) | (45.4 M) | (47.6 M) |
Orthopediatrics Corp and related stocks such as Treace Medical Concepts, CeriBell, and SurModics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Orthopediatrics Corp financial statement analysis. It represents the amount of money remaining after all of Orthopediatrics Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Orthopediatrics Corp | KIDS |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 2850 Frontier Drive, |
| Exchange | NASDAQ Exchange |
USD 16.9
Additional Tools for Orthopediatrics Stock Analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.